First patients to test new cancer pill in groundbreaking safety trial
Disease control
Recruiting now
This is the first time a new oral drug called SIGX1094R is being tested in people. The main goal is to find a safe dose and understand its side effects in patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will also check if takin…
Phase: PHASE1 • Sponsor: Signet Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC